PMVP
PMV Pharmaceuticals, Inc.
Latest Form 4:Sale$1.5MbyORBIMED ADVISORS LLC (10% Owner) · filed Oct 27, 2025
PMV Pharmaceuticals, Inc. (PMVP) has 3 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 29, 2025.
Insiders have net sold $2.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:David H. Mack
- Employees:54
- HQ:Princeton, NJ, US
- IPO:2020-09-25
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Related companies
PMV Pharmaceuticals, Inc. is in the Healthcare sector.